Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00555061 · ClinicalTrials.gov registry record · Phase 4
Pharmacokinetics of Retapamulin in Pediatric Subjects With Uncomplicated Skin Infections.
A Phase 4 study of Skin Infections, Bacterial, sponsored by GlaxoSmithKline.
- Completed
- Registry status
- Phase 4
- Development phase
- 60
- Enrollment target
- 20
- Study locations
NCT00555061 is a Phase 4 study of Skin Infections, Bacterial that has completed, run by GlaxoSmithKline. The registered enrollment target is 60 participants. The trial reports 20 study locations across 11 states.
The verdict
NCT00555061, a Phase 4 study of Skin Infections, Bacterial, has completed, sponsored by GlaxoSmithKline.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 60 participants
- Enrollment target
- 20
- Study locations
Study Summary
A study to evaluate the pharmacokinetics of Retapamulin Ointment, 1%, in pediatric subjects (2-24 months) with secondarily-infected traumatic lesions, secondarily-infected dermatoses, or impetigo (bullous and non-bullous).
Conditions Studied
Interventions
- DRUG Retapamulin Ointment, 1%
Study Locations (20)
Other
- GSK Investigational Site - San José
- GSK Investigational Site - México
- GSK Investigational Site - Alphen aan den Rijn
- GSK Investigational Site - Losser
- GSK Investigational Site - Roelofarendsveen
- GSK Investigational Site - Rotterdam
North Rhine-Westphalia
- GSK Investigational Site - Bochum
- GSK Investigational Site - Erkrath
- GSK Investigational Site - Goch
- GSK Investigational Site - Kleve-Materborn
Buenos Aires
- GSK Investigational Site - Ciudad Autonoma de Buenos Aires
- GSK Investigational Site - Ciudad Autonoma de Buenos Aires
Alabama
- GSK Investigational Site - Tuscaloosa
Arkansas
- GSK Investigational Site - Bentonville
California
- GSK Investigational Site - Orange
Massachusetts
- GSK Investigational Site - Woburn
Ohio
- GSK Investigational Site - Cleveland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2007-09 |
| Est. Completion | 2008-08 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00555061
The ClinicalTrials.gov registry entry for NCT00555061 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is GlaxoSmithKline, which has 1,345 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Skin Infections, Bacterial appearing as the primary indexed condition, and to 1 intervention - of which Retapamulin Ointment, 1% is the first listed.
NCT00555061 reports 20 study locations spanning 11 distinct geographic areas - top geographies include Other, North Rhine-Westphalia, Buenos Aires.
Frequently Asked Questions
What is clinical trial NCT00555061 about?
NCT00555061 is a clinical study titled "Pharmacokinetics of Retapamulin in Pediatric Subjects With Uncomplicated Skin Infections.". A study to evaluate the pharmacokinetics of Retapamulin Ointment, 1%, in pediatric subjects (2-24 months) with secondarily-infected traumatic lesions, secondarily-infected dermatoses, or impetigo (bullous and non-bullous).
What is the current status of trial NCT00555061?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 60 participants. The study started on 2007-09. Estimated completion is 2008-08.
What conditions does trial NCT00555061 study?
This clinical trial studies the following conditions: Skin Infections, Bacterial.
What interventions are being tested in trial NCT00555061?
The interventions under investigation include: Retapamulin Ointment, 1% (DRUG).
Who is sponsoring clinical trial NCT00555061?
This trial is sponsored by GlaxoSmithKline, which has 1,345 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00555061 being conducted?
This trial has 20 study locations across Alabama, Arkansas, California, Massachusetts, Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Skin Infections, Bacterial
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.